Suchergebnisse - "Curigliano, G"

PubPharm (14)

1

Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer

enthalten in: ESMO open | 2024

von Curigliano, G. | Dent, R. | Earle, H. | +4

2

Prognostic value of HER2DX in early-stage HER2-positive breast cancer : a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)

enthalten in: ESMO open | 2024

von Villacampa, G. | Pascual, T. | Brasó-Maristany, F. | +17

3

Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD)

enthalten in: ESMO open | 2024

von Incorvaia, L. | Badalamenti, G. | Novo, G. | +18

4

Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure

enthalten in: ESMO open | 2023

von Antonarelli, G. | Corti, C. | Tarantino, P. | +7

5

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Tarantino, P. | Viale, G. | Press, M. | +29

CommentIn: Ann Oncol. 2023 Oct;34(10):948-949. - PMID 37499869

6

Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Curigliano, G. | Dunton, K. | Rosenlund, M. | +5

7

Targeting HER3 for cancer treatment : a new horizon for an old target

enthalten in: ESMO open | 2023

von Uliano, J. | Corvaja, C. | Curigliano, G. | +1

8

ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Paluch-Shimon, S. | Cardoso, F. | Partridge, A. | +20

9

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Cardoso, F. | Paluch-Shimon, S. | Senkus, E. | +42

10

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Criscitiello, C. | Bayar, M. | Curigliano, G. | +12